Loading company details...
Beta
Latest Form 4 (Oct 15, 2026): Harry Kovelman (Chief Medical Officer): Grant/Award of 32,500 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 15, 2026 | Harry Kovelman, Chief Medical Officer | Grant/Award | 32,500 | n/a |
| Oct 15, 2026 | Harry Kovelman, Chief Medical Officer | Sale | 15,844 | $20.1K |
| Oct 15, 2026 | David A. Henry, Chief Financial Officer | Grant/Award | 51,250 | n/a |
| Oct 15, 2026 | Paul R. Gudonis, Chief Executive Officer | Grant/Award | 71,250 | n/a |
| Oct 13, 2026 | David A. Henry, Chief Financial Officer | Grant/Award | 6,272 | n/a |
| Oct 13, 2026 | Paul R. Gudonis, Chief Executive Officer | Grant/Award | 8,363 | n/a |
| Oct 13, 2026 | Mary-Katherine Hale McClure, Chief Commericial Officer | Grant/Award | 275,000 | n/a |
| Sep 4, 2026 | Milton Mayo Morris | Sale | 15,000 | $21.1K |
| Aug 24, 2026 | Harry Kovelman, Chief Medical Officer | Sale | 17,500 | $30.3K |
| Aug 11, 2026 | Harry Kovelman, Chief Medical Officer | Grant/Award | 55,149 | n/a |